Clinical Study
Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
Table 2
Prevalence of NAFLD and serum liver enzymes throughout the study in SCH patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values for quantitative data are expressed as mean ± standard deviation; values for categorical variables are expressed as number (percentage). value for comparing variables between mild SCH-LT4 group and mild SCH-control group. # value for comparing variables between baseline and end-of-study within each group. NAFLD: nonalcoholic fatty liver disease; SCH: subclinical hypothyroidism; LT4: levothyroxine; ALT: alanine aminotransferase; AST: aspartate aminotransferase. |